Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY CAFFEINE ADDICTION INCLUDING EUODIA EXTRACT OR EVODIAMINE AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2018/105960
Kind Code:
A1
Abstract:
The present invention relates to a composition which is for preventing or treating caffeine addiction and includes evodiamine or euodia extract. More specifically, the present invention relates to a pharmaceutical composition which has an effect of preventing or alleviating somnipathy and central nervous system excitation caused by caffeine. In addition, the present invention relates to a caffeine addiction treatment method and a health functional food composition including euodia extract or evodiamine.

Inventors:
JANG CHOON GON (KR)
Application Number:
PCT/KR2017/014021
Publication Date:
June 14, 2018
Filing Date:
December 01, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SG CORP (KR)
RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV (KR)
International Classes:
A61K31/519; A23L33/10; A23L33/105; A61K31/407; A61K36/754
Foreign References:
US20120322813A12012-12-20
KR880001296Y11988-04-02
KR20160085581A2016-07-18
KR20140086213A2014-07-08
Other References:
TSAI, T.-H. ET AL.: "Effects of Evodia Rutaecarpa and Rutaecarpine on the Pharmacokinetics of Caffeine in Rats", PLANLA MEDICA, vol. 71, no. 7, 2005, pages 640 - 645, XP055609574, DOI: 10.1055/s-2005-871270
NOH, K. ET AL.: "Effects of Rutaecarpine on the Metabolism and Urinary Excretion of Caffeine in Rats", ARCHIVES OF PHARMACAL RESEARCH, vol. 34, no. 1, 2011, pages 119 - 125, XP019893773
SEO, Y. M. ET AL.: "Effects of Rutaecarpine on the Pharmacokinetics of Caffeine and Its Three Metabolites in Rats", BIOMOLECULES & THERAPEUTICS, vol. 19, no. 2, 2011, pages 243 - 247, XP055510773
See also references of EP 3552606A4
Attorney, Agent or Firm:
LEE, Myoung-Jin (KR)
Download PDF: